Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T01:55:55.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Differential infectivity and immunopathology in murine experimental infections by two natural clones belonging to the Trypanosoma cruzi I lineage

Published online by Cambridge University Press:  09 March 2005

E. GARZON ,
F. GENNA ,
M. F. BOSSENO ,
J. SIMONY-LA FONTAINE ,
M. RADAL ,
D. SERENO ,
F. MATHIEU-DAUDE ,
A. OUAISSI  and
S. F. BRENIÈRE
E. GARZON
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
F. GENNA
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
M. F. BOSSENO
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
J. SIMONY-LA FONTAINE
Affiliation:
Département d'Anatomopathologie, CRLC Val d'Aurelle-Paul Lamarque, Parc Euromédecine, 34298, Montpellier cédex 5, France
M. RADAL
Affiliation:
Département d'Anatomopathologie, CRLC Val d'Aurelle-Paul Lamarque, Parc Euromédecine, 34298, Montpellier cédex 5, France
D. SERENO
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
F. MATHIEU-DAUDE
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
A. OUAISSI
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
S. F. BRENIÈRE
Affiliation:
Institut de Recherche pour le Développement, IRD, UR 008 “Pathogénie et Epidémiologie des Trypanosomatidés”, 911 Av. Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
Get access Rights & Permissions [Opens in a new window]

Abstract

Immunopathology of Chagas' disease in Balb/c mice infected with 2 Trypanosoma cruzi clones, belonging to the T. cruzi I lineage and presenting different in vitro virulence (P/209 cl1>SO34 cl4) was compared. In the acute phase, evading mechanisms such as parasite-induced lymphocyte polyclonal activation and T cell immunosuppression were higher in mice infected with the clone giving a higher parasitaemia (P/209 cl1). A similar increase of non-specific isotypes was observed in both infections with IgG2a prevalence. Interestingly, CD8+ cell hypercellularity and lymphocyte immunosuppression were observed during the chronic phase (245 days post-infection) in mice infected by the most virulent clone. In the same way, the parasite-specific antibody response was more intense in P/209 cl1-infected mice over the acute phase. During the chronic phase this response remarkably dropped down in SO34 cl4-infected mice exclusively. Finally, P/209 cl1-infected mice presented a more severe inflammation and tissue damage in heart and quadriceps than SO34 cl4-infected mice. This comparative study showed differences between the two clones: a higher virulence in vivo being clearly associated with a greater ability to induce evasion mechanisms and severe tissue damage.

Keywords

Trypanosoma cruzigenotypeimmunopathologyvirulencemouse
Type
Research Article
Information
Parasitology , Volume 131 , Issue 1 , July 2005 , pp. 109 - 119
Copyright
© 2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

ANDRADE, S. G. & MAGALHAES, J. B. ( 1996). Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Revista da Sociedade Brasileira de Medicina Tropical 30, 27–35.Google Scholar
BARRETT, M. P., BURCHMORE, R. J., STICH, A., LAZZARI, J. O., FRASCH, A. C., CAZZULO, J. J. & KRISHNA, S. ( 2003). The trypanosomiases. Lancet 362, 1469–1480.CrossRefGoogle Scholar
BARNABÉ, C., BRISSE, S. & TIBAYRENC, M. ( 2000). Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach. Parasitology 120, 513–526.CrossRefGoogle Scholar
BOSSENO, M. F., BARNABE, C., MAGALLON GASTELUM, E., LOZANO KASTEN, F., RAMSEY, J., ESPINOZA, B. & BRENIERE, S. F. ( 2002). Predominance of Trypanosoma cruzi lineage I in Mexico. Journal of Clinical Microbiology 40, 627–632.CrossRefGoogle Scholar
BRENER, Z. ( 1962). Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4, 389–396.Google Scholar
BRENIÈRE, S. F., CARRASCO, R., REVOLLO, S., APARICIO, G., DESJEUX, P. & TIBAYRENC, M. ( 1989). Chagas' disease in Bolivia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. American Journal of Tropical Medicine and Hygiene 41, 521–529.CrossRefGoogle Scholar
BRENIÈRE, S. F., BRAQUEMOND, P., SOLARI, A., AGNÈSE, J. F. & TIBAYRENC, M. ( 1991). An isoenzyme study of naturally occurring clones of Trypanosoma cruzi isolated from both sides of the West Andes highland. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 62–66.CrossRefGoogle Scholar
BRISSE, S., DUJARDIN, J. C. & TIBAYRENC, M. ( 2000). Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Molecular and Biochemical Parasitology 111, 95–105.CrossRefGoogle Scholar
CARNEIRO, M., ROMANHA, A. J. & CHIARI, E. ( 1991). Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Memorias do Instituto Oswaldo Cruz 86, 387–393.CrossRefGoogle Scholar
CLARK, C. G. & PUNG, O. J. ( 1994). Host specificity of ribosomal DNA variation in sylvatic Trypanosoma cruzi from North America. Molecular and Biochemical Parasitology 66, 175–179.CrossRefGoogle Scholar
DE DIEGO, J. A., PAULAU, M. T. & PENIN, P. ( 1998). Are genotypes of Trypanosoma cruzi involved in the challenge of chagasic cardiomyopathy? Parasitology Research 84, 147–152.Google Scholar
DI NOIA, J. M., BUSCAGLIA, C. A., DE MARCHI, C. R., ALMEIDA, I. C. & FRASCH, A. C. ( 2002). A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. The Journal of Experimental Medicine 195, 401–413.CrossRefGoogle Scholar
DOS SANTOS, P. V., ROFFE, E., SANTIAGO, H. C., TORRES, R. A., MARINO, A. P., PAIVA, C. N., SILVA, A. A., GAZZINELLI, R. T. & LANNES-VIEIRA, J. ( 2001). Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes and Infection 3, 971–984.CrossRefGoogle Scholar
DOST, C. K., SARAIVA, J., MONESI, N., ZENTGRAF, U., ENGELS, W. & ALBUQUERQUE, S. ( 2004). Six Trypanosoma cruzi strains characterized by specific gene expression patterns. Parasitology Research, Aug 19 [Epub ahead of print].CrossRef
FRANCOLINO, S. S., ANTUNES, A. F., TALICE, R., ROSA, R., SELANIKIO, J., DE REZENDE, J. M., ROMANHA, A. J. & DIAS, J. C. ( 2003). New evidence of spontaneous cure in human Chagas' disease. Revista da Sociedade Brasileira de Medicina Tropical 36, 103–107.CrossRefGoogle Scholar
GARZON, E., BORGES, M. C., CORDEIRO-DA-SILVA, A., NACIFE, V., MEIRELLES MDE, N., GUILVARD, E., BOSSENO, M. F., GUEVARA, A. G., BRENIERE, S. F. & OUAISSI, A. ( 2003). Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice. Immunology Letters 89, 67–80.CrossRefGoogle Scholar
HIGO, H., YANAGI, T., MATTA, V., AGATSUMA, T., KANBARA, H., TADA, I., DE LEON, M. P., MONROY, C. & TABARU, Y. ( 1997). Genetic structure of Trypanosoma cruzi in Central America and its comparison with South American strains. International Journal for Parasitology 27, 1369–1374.CrossRefGoogle Scholar
KALIL, J. & CUNHA-NETO, E. ( 1996). Autoimmunity in Chagas Disease cardiomyopathy: Fulfilling the criteria at last? Parasitology Today 12, 396–398.Google Scholar
KIERSZENBAUM, F., LOPEZ, H. M. & SZTEIN, M. B. ( 1994). Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas'disease. Immunology 81, 462–467.Google Scholar
KRAUTZ, G. M., KISSINGER, J. C. & KRETTLI, A. U. ( 2000). The targets of the lytic antibody response against Trypanosoma cruzi. Parasitology Today 16, 31–34.CrossRefGoogle Scholar
LAURENT, J. P., BARNABÉ, C., QUESNEY, V., NOEL, S. & TIBAYRENC, M. ( 1997). Impact of clonal evolution on the biological diversity of Trypanosoma cruzi. Parasitology 114, 213–218.CrossRefGoogle Scholar
LEON, J. S. & ENGMAN, D. M. ( 2003). The significance of autoimmunity in the pathogenesis of Chagas heart disease. Frontiers in Bioscience 8, 315–322.Google Scholar
MARINHO, C. R., D'IMPERIO LIMA, M. R., GRISOTTO, M. G. & ALVAREZ, J. M. ( 1999). Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infection and Immunity 67, 308–318.Google Scholar
MILES, M. A., CEDILLOS, R. A., POVOA, M. M., DE SOUZA, A. A., PRATA, A. & MACEDO, V. ( 1981). Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease? Lancet 20, 1338–1340.Google Scholar
MINOPRIO, P. ( 2001). Parasite polyclonal activators: new targets for vaccination approaches? International Journal for Parasitology 31, 588–591.Google Scholar
MINOPRIO, P. M., EISEN, H., FORNI, L., D'IMPERIO LIMA, M. R., JOSKOWICZ, M. & COUTINHO, A. ( 1986). Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scandinavian Journal of Immunology 24, 661–668.Google Scholar
MOMEN, H. ( 1999). Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature. Memorias do Instituto Oswaldo Cruz 94 (Suppl.) 181–184.CrossRefGoogle Scholar
MONTILLA, M. M., GUHL, F., JARAMILLO, C., NICHOLLS, S., BARNABE, C., BOSSENO, M. F. & BRENIERE, S. F. ( 2002). Isoenzyme clustering of Trypanosomatidae Colombian populations. American Journal of Tropical Medicine and Hygiene 66, 394–400.CrossRefGoogle Scholar
MOSER, D. R., KIRCHHOFF, L. V. & DONELSON, J. E. ( 1989). Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. Journal of Clinical Microbiology 27, 1477–1482.Google Scholar
OUAISSI, A., DA SILVA, A. C., GUEVARA, A. G., BORGES, M. & GUILVARD, E. ( 2001). Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting. Journal of Biomedicine and Biotechnology 1, 11–17.CrossRefGoogle Scholar
REINA-SAN-MARTIN, B., COSSON, A. & MINOPRIO, P. ( 2000). Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitology Today 16, 62–67.CrossRefGoogle Scholar
REVOLLO, S., OURY, B., LAURENT, J. P., BARNABE, C., QUESNEY, V., CARRIERE, V., NOEL, S. & TIBAYRENC, M. ( 1998). Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology 89, 30–39.CrossRefGoogle Scholar
RISSO, M. G., GARBARINO, G. B., MOCETTI, E., CAMPETELLA, O., GONZALEZ CAPPA, S. M., BUSCAGLIA, C. A. & LEGUIZAMON, M. S. ( 2004). Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. Journal of Infectious Diseases 189, 2250–2259.CrossRefGoogle Scholar
SOUTO, R. P., FERNANDES, O., MACEDO, A. M., CAMPBELL, D. A. & ZINGALES, B. ( 1996). DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology 83, 141–152.CrossRefGoogle Scholar
SPINELLA, S., MILON, G. & HONTEBEYRIE-JOSKOWICZ, M. ( 1990). A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo. European Journal of Immunology 20, 1045–1051.CrossRefGoogle Scholar
STEINDEL, M., TOMA, H. K., ISHIDA, M. M., MURTA, S. M., DE CARVALHO PINTO, C. J., GRISARD, E. C., SCHLEMPER BR, J. R., RIBEIRO-RODRIGUES, R. & ROMANHA, A. J. ( 1995). Biological and isoenzymatic characterization of Trypanosoma cruzi strains isolated from sylvatic reservoirs and vectors from the state of Santa Catarina, Southern Brazil. Acta Tropica 60, 167–177.CrossRefGoogle Scholar
TAIBI, A., ESPINOZA, A. G. & OUAISSI, A. ( 1995). Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease. Immunology Letters 48, 193–200.CrossRefGoogle Scholar
TOLEDO, M. J., DE LANA, M., CARNEIRO, C. M., BAHIA, M. T., MACHADO-COELHO, G. L., VELOSO, V. M., BARNABE, C., TIBAYRENC, M. & TAFURI, W. L. ( 2002). Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Experimental Parasitology 100, 161–172.CrossRefGoogle Scholar
WORLD HEALTH ORGANIZATION ( 2002). Control of Chagas Disease. Second Report of the WHO Expert committee, Geneva.
ZINGALES, B., STOLF, B. S., SOUTO, R. P., FERNANDES, O. & BRIONES, M. R. ( 1999). Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Memorias do Instituto Oswaldo Cruz 94 (Suppl 1), 159–164.CrossRefGoogle Scholar